Leading Exporters and Wholesaler of Docetero Rtu 40mg Docetaxel Injection, Docetero Rtu 80mg Docetaxel Injection, Domvel 60mg Denosumab Injection, Doxotero 50mg Doxorubicin Hydrochloride Injection, Eleftha 440mg Trastuzumab Injection, Encicarb 500mg Ferric Carboxymaltose Injection, Epiruba 50mg Epirubicin Hydrochloride Injection, Erlotero 100mg Erlotinib Tablet, Etovel 50mg Etoposide Capsule, Evermil 5mg Everolimus Tablet, Fasnorm 250mg Fulvestrant Injection, Femistra 1mg Anastrozole Tablet, Fempro 2.5mg Letrozole Tablet, Geffy 250mg Gefitinib Tablet, Geftinat 250mg Gefitinib Tablet, Gemivo 1gm Gemcitabine Injection, Gemivo 200mg Gemcitabine Injection, Glenza 40mg Enzalutamide Capsule, Glenza 80mg Enzalutamide Capsule, Glioz 20mg Temozolomide Capsule, Herduo 250mg Lapatinib Tablet and Hertab 250mg Lapatinib Tablet from Delhi.
| Business Type | Exporter, Supplier |
| Brand Name | Docetero |
| Packaging Type | Vial |
| Packaging Size | 6 Ml |
| Form Of Medicine | Liquid |
| Strength | 120 Mg |
| Indication | Breast Cancer |
| Manufacturer | Hetero Healthcare Ltd |
| Salt Composition | Docetaxel |
Docetero RTU 120mg Injection belongs to the class of anticancer medications known as taxoids. It contains the active constituent Docetaxel indicated to treat breast, prostate, non-small cell lung, stomach, and head and neck cancer. Cancer is a disease in which cells multiply in an uncontrolled and abnormal manner. This chemotherapy medication is used alone or in combination with other anticancer medicines.
The common side effects that are likely to be associated with Docetero RTU 120mg Injection are dizziness, headache, fever, infections, loss of appetite, sleeping trouble, joint or muscle pain, eye problems, weight loss, tiredness, dry mouth, reduced blood pressure, hair loss, etc. Inform your doctor if any of these side effects disturb or persist in you.
Inform your doctor if you are allergic to Docetero RTU 120mg Injection and its ingredients. Before taking this medication, you must inform your physician if you have kidney and heart problems, vision problems, epilepsy, or alcohol addiction. It is contraindicated in patients with very few white blood cells or severe liver diseases. Ensure to inform your physician about all the medicines, including supplements and herbal medicines, that you are taking before starting Docetero RTU 120mg Injection treatment. Use effective birth control during the treatment and at least six months after the last dose.
| Business Type | Exporter, Supplier |
| Packaging Type | Vial |
| Brand Name | Docetero |
| Packaging Size | 4ml |
| Form Of Medicine | Liquid |
| Strength | 80 Mg |
| Indication | Breast Cancer |
| Manufacturer | Hetero Healthcare Ltd |
| Salt Composition | Docetaxel |
Docetero RTU 80mg Injection belongs to the class of anticancer medications known as taxoids. It contains the active constituent Docetaxel indicated to treat breast, prostate, non-small cell lung, stomach, and head and neck cancer. Cancer is a disease in which cells multiply in an uncontrolled and abnormal manner. This chemotherapy medication is used alone or in combination with other anticancer medicines.
The common side effects that are likely to be associated with Docetero RTU 80mg Injection are dizziness, headache, fever, infections, loss of appetite, sleeping trouble, joint or muscle pain, eye problems, weight loss, tiredness, dry mouth, reduced blood pressure, hair loss, etc. Inform your doctor if any of these side effects disturb or persist in you.
Inform your doctor if you are allergic to Docetero RTU 80mg Injection and its ingredients. Before taking this medication, you must inform your physician if you have kidney and heart problems, vision problems, epilepsy, or alcohol addiction. It is contraindicated in patients with very few white blood cells or severe liver diseases. Ensure to inform your physician about all the medicines, including supplements and herbal medicines, that you are taking before starting Docetero RTU 80mg Injection treatment. Use effective birth control during the treatment and at least six months after the last dose.
| Business Type | Exporter, Supplier |
| Packaging Size | 1 Ml |
| Brand Name | Domvel |
| Packaging Type | Box |
| Dose/Strength | 60 Mg |
| Composition | Denosumab 60mg/ml |
| Marketer | Eris Lifescience Ltd |
Domvel 60mg injection consists of the active ingredient Denosumab. It is a medication used to treat osteoporosis, characterized by weakened bones. It is also prescribed to prevent bone complications in patients with certain types of cancer, such as multiple myeloma and bone metastases. Domvel 60mg injection works by inhibiting a protein called RANK ligand, which plays a role in the breakdown of bone tissue. Studies proved it can significantly increase bone density, reducing fracture risk in postmenopausal women with osteoporosis and patients with cancer-related bone loss. Close monitoring of renal function may be necessary for patients with moderate renal impairment.
Domvel 60mg injection should not be used in individuals with known hypersensitivity or allergic reactions to its components. Adequate calcium and vitamin D supplementation is required to ensure during the treatment. It is not approved for use in children and adolescents. Its safety and effectiveness in pediatric populations have not been established, so its use is contraindicated in individuals under 18. This medication should be used cautiously in individuals with pre-existing hypoparathyroidism, characterized by low parathyroid hormone levels.
| Business Type | Exporter, Supplier |
| Packaging | Vial |
| Strength | 50 Mg |
| Pack Size | 25 Ml |
| Brand | Celon Labs |
| Manufacturer | HETERO HEALTHCARE LTD |
| Storage Condition | Refrigerate (2-8°C) |
| Salt Composition | Doxorubicin Hydrochloride Injection |
Doxilyd 50mg Injection is a chemotherapy drug containing the active constituent doxorubicin. It belongs to the medication class known as cytotoxic agents. It treats many types of cancers, such as lung, breast, blood, bladder, stomach, etc. It may be given alone or in combination with other anticancer medicines. Cancer is a condition in which cells multiply uncontrolled and abnormally.
Before starting treatment with Doxilyd 50mg Injection, it is very important to tell your physician if you have or had any history of severe heart disorders, liver disorders, and hypersensitivity. Notify your doctor if you are taking or have ever received certain cancer chemotherapy medications. Avoid live vaccines during the treatment.
Do not take this medicine if you are pregnant or breastfeeding because this may cause harm to the unborn baby, and use effective birth control during the treatment with this medication. Doxilyd 50mg medicine may reduce fertility temporarily in men. So it is advised to get suggestions about fertility concerns from your doctor. Discuss with your physician if you are on a salt-controlled diet because this Injection contains sodium. Do not stop taking this medication without talking to your physician first.
| Business Type | Exporter, Supplier |
| Strength | 440 Mg |
| Manufacturer | Intas |
| Brand Name | Eleftha |
| Packaging | Vial |
| Shelf Life | 36 Months |
| Treatment | Breast Cancer, Gastric Cancer |
| Drug Type | Standard Trastuzumab |
| Storage Temperature | 2-8 Degree C |
Eleftha 440mg Injection consists of Trastuzumab as an active constituent which is indicated for its use in HER 2 breast cancer. In HER 2 positive patients, the breast cancer cells are mostly composed of HER2 proteins that cause rapid development of cancer tumor by serving as a signal to the cancerous. This medication is also used to treat metastatic gastric cancer with increased levels of HER2 proteins.
Her 2 positive breast cancer are most aggressive in nature. The targeted therapy for her 2 positive breast cancer works by selectively targeting the proteins that are responsible for the growth, development, and spread of cancer. Use effective birth control during the treatment and for at least 7 months after the final dose.
Eleftha 440mg Injection is not recommended for patients aged under 18, patients who have severe breathing problems or need oxygen treatment. It is necessary to let your physician know if you have any heart problems, breathlessness, or have ever had any other cancer treatment. Make sure you inform your physician of all the medicines, including supplements and herbal medicines, you are taking before you start treatment with this medication.
| Business Type | Exporter, Supplier |
| Packaging Size | 10 Ml |
| Packaging Type | Vial |
| Brand Name | Encicarb |
| Strength | 500mg |
| Manufactured By | EMCURE PHARMACEUTICALS LTD |
| Salt Composition | Ferric Carboxymaltose Injection |
Encicarb 500mg injection contains the active substance Ferric carboxymaltose. It belongs to the group of medications called iron replacement products. It is used to treat iron-deficiency anemia (decreased RBC due to lower levels of iron in the body) in adults and pediatric patients who cannot tolerate oral iron or when oral iron supplements are ineffective. It is also indicated to treat iron deficiency anemia in adults with chronic kidney disease who are not on dialysis. This medicine is not recommended for pediatric patients less than one year of age.
Do not take this medicine if you are allergic to ferric carboxymaltose or any of the other ingredients of this medicine. Do not receive Encicarb 500mg injection if you have anemia that is not caused by iron deficiency, an iron overload (too much iron in the body), or difficulties in using iron. Inform your physician if you have rheumatoid arthritis, severe asthma, eczema, infection, liver disorders, or low phosphate levels in the blood. Incorrect administration of this injection may cause irritation and long-lasting discoloration at the administration site.
Inform your physician if you are pregnant or breastfeeding before initiating the treatment with Encicarb 500mg injection. The most common side effects are nausea, hypertension, flushing, injection site reactions, skin reactions, vomiting, and dizziness. Tell your physician if you have experienced serious allergic (hypersensitive) reactions to other injectable iron preparations.
| Business Type | Exporter, Supplier |
| Packaging | Vial |
| Brand | Epiruba |
| Strength | 50 Mg |
| Strength Per Ml | 50mg |
| Composition | Epirubicin HCl |
| Indication | Breast Cancer |
| Storage Temp | Below 25°C |
Epirubicin is an antineoplastic drug that belongs to the class anthracyclines. FDA approved epirubicin on November 15, 2006, for the treatment of breast cancer, stomach, and bowel cancer, ovarian cancer, and lung cancer.
Uses of EPIRUBICINEpirubicin is an intravenously administered drug. This medicine is used as adjuvant therapy in combination with other medications to treat breast cancer in patients who have had surgery to remove the tumor. It is also useful in treating breast, ovaries, stomach, bowel, and lung cancers. In addition, this medicine is also used to treat cancers of the blood-forming tissues, such as malignant lymphomas, leukemias, and multiple myeloma.
| Business Type | Exporter, Supplier |
| Form | Tablet |
| Usage | Non-Small Cell Lung Cancer |
| Brand | Erlotero |
| Strength | 100 Mg |
| Composition | Erlotinib |
| Packaging | Bottle |
| Tablets Per Pack | 30 Tablets |
Erlotero 100mg Tablet is used in the treatment of non-small cell lung cancer and pancreatic cancer.
Erlotero 100mg Tablet should be taken on an empty stomach or should be taken one hour before or 2 hour after meal. You should continue to take it as long as your doctor advises it. The duration of treatment varies according to your needs and response to treatment. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
The most common side effects of this medicine include nausea, vomiting, fatigue, rash, and weight loss. It may cause severe diarrhea, drink plenty of fluids or consult with your doctor if it bothers you. It makes you sensitive towards sunlight, hence wear protective clothing or use sunscreen while going out. In case you develop ulceration in mouth, changes in your vision, or breathing difficulties than it is better to inform the doctor. Your doctor may advise for regular monitoring of liver function while you are taking this medicine.
Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. It is advised to quit smoking while taking this medicine as it can affect the working of the medicine. If you have to take an antacid or any other medicine, take it at a gap of at least 2 hours after taking the cancer medicine.
| Business Type | Exporter, Supplier |
| Dosage Form | Capsule |
| Composition | Etoposide |
| Brand | Etovel |
| Strength | 50 Mg |
| Packaging Size | 8 Capsules |
| Manufactured By | GLS |
| Salt Composition | Etoposide Capsules |
Etovel 50mg capsule is an anticancer drug with the ingredient Etoposide. It belongs to the medication class known as cytostatic. It is used to treat certain types of cancers such as testicular cancer, small-cell lung cancer, acute myeloid leukemia (blood cancer), tumor in the lymphatic system (Hodgkin’s lymphoma, non-Hodgkin’s lymphoma), and ovarian cancer in adults.
Talk to your doctor if you had or currently having radiotherapy or chemotherapy. Report to your doctor if you have any infections or low levels of protein (albumin) in your blood. Etovel 50mg capsule should not be taken if you have recently been vaccinated with yellow fever or any live vaccines. Before starting treatment with this medicine, it is very important to tell your physician if you currently or previously had any medical conditions of kidney problems or liver disorders.
Both women and men should use effective birth control during the treatment and at least 6 months after the last dose. In men, it is recommended not to father a child during and up to 6 months after the treatment. So it is advised to get suggestions about fertility concerns from your doctor. Administration of the Etovel 50mg capsule may cause a reduction in the level of blood cells and increase the risk of developing infections. So, your doctor may perform blood tests regularly to monitor your kidney and liver function. It is unknown whether it is safe to use on a child.
| Business Type | Exporter, Supplier |
| Usage | Advanced Breast Cancer |
| Packaging Type | Box |
| Strength | 5 Mg |
| Brand | Evermil |
| Tablets Per Pack | 10 Tablets |
| Form | Tablet |
| Salt Composition | Everolimus Tablets |
| Marketer | GLENMARK PHARMACEUTICALS LTD |
Evermil 5mg tablet is an antineoplastic drug belonging to the class of mTOR kinase inhibitors, containing the active ingredient everolimus. It is used to treat advanced breast cancer, renal cell carcinoma, pancreatic neuroendocrine tumours, and also in the treatment of subependymal giant cell astrocytoma (tumours are found in the ventricles of the brain). Good oral hygiene and regular dental check-ups are important during the treatment since this medicine can cause sores or ulcers in the mouth. It is often combined with cyclophosphamide, an alkylating agent, to treat subependymal giant cell astrocytoma.
Before taking this medicine, it is necessary to know that your risk of getting bacterial or viral infection increases with this treatment. If you have been infected with Hepatitis B, Evermil 5mg tablet increases the chances of reinfection. Tell your healthcare provider if you experience fever, chills, cough, yellowing of the skin, joint pain, or swelling during this treatment. You must limit your exposure to sunlight and UV light by wearing protective clothing and applying sunscreen frequently, as this medicine may increase the risk of developing cancers. Avoid taking grapefruit juice or grapefruit while taking this medicine.
This tablet is not recommended for adolescents and children under the age of 18. Contact your doctor immediately if you experience shortness of breath, chest pain, or worsening cough. During the Evermil 5mg tablet treatment, your doctor may periodically monitor your white blood cell counts, platelets, blood sugar, electrolytes, and kidney parameters to prevent serious complications. This medicine has the potential to cause kidney problems. Report to your doctor if you have been diagnosed with liver disorders, heart failure, high blood cholesterol levels, or hypertension before starting this treatment. Avoid live vaccines and close contact with those who have received live vaccines.
| Business Type | Exporter, Supplier |
| Packaging Type | Box |
| Packaging Size | 5ml |
| Brand Name | Fasnorm |
| Strength | 250 Mg |
| Volume | 5 Ml |
| Treatment | ER+ Metastatic Breast Cancer |
| Manufactured By | Biocon Ltd |
| Salt Composition | Fulvestrant 250mg Injection |
Fasnorm 250mg Injection contains the active substance fulvestrant. It is an antineoplastic drug that belongs to the class estrogen receptor antagonist. Estrogen, a type of female sex hormone, can sometimes be involved in the growth of breast cancer. This medicine is used alone to treat postmenopausal women with a certain type of breast cancer called estrogen receptor-positive breast cancer that is locally advanced or spread to other parts of the body. It is also indicated in combination with other anti-cancer medication to treat women with certain types of breast cancer called hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, which is locally advanced or spread to other parts of the body.
Do not take this injection if you are allergic to Fasnorm 250mg Injection or any other ingredients of this medicine, pregnant or breastfeeding, or have severe liver problems. Before initiating the treatment, inform your physician if you have kidney or liver problems, bone diseases, bleeding disorders, and heart diseases. Fasnorm 250mg Injection is not indicated in children and adolescents under 18 years. Report to your physician if you have allergic reactions, including swelling of the face, lips, tongue, or throat, after administering this injection.
Common side effects of Fasnorm 250mg Injection are pain or inflammation at the site of injection, abnormal levels of liver enzymes, nausea, headache, cough, weakness or tiredness, joint and muscle pain, hot flashes, hair loss, and skin rash. Your doctor may advise you to take certain blood tests while receiving this injection. This injection may increase your risk of bleeding and liver failure. Female patients of reproductive potential should use effective contraception during treatment with this injection and for two years after the last dose.
| Business Type | Exporter, Supplier |
| Packaging Size | 1*10 Tablets |
| Brand Name | Femistra |
| Usage | Breast Cancer |
| Strength | 1 Mg |
| Packaging Type | Box |
| Form | Tablet |
| Manufactured By | ZYDUS |
| Salt Composition | Anastrozole Tablets |
Femistra 1mg tablet is an anticancer drug with the ingredient Anastrozole. It belongs to the medication class known as aromatase inhibitors. It is used to treat hormone-dependent breast cancer in postmenopausal women. Aromatase inhibitors reduce estrogen levels by preventing an enzyme in adipose tissue from converting other hormones into estrogen. This medication helps to delay the recurrence of early-stage breast cancer.
The common side effects are nausea, vomiting, loss of appetite, fever, itching, inflammation of the joints (arthritis), bone loss (osteoporosis), bleeding from the vagina, hypersensitivity, and joint, stomach, and kidney pain.
If you are allergic to Anastrozole or its ingredients, tell your doctor before starting treatment with this medication. Tell your doctor if you are still experiencing menstruation and have not yet reached menopause, have osteoporosis, or have any liver or kidney problems. If you are lactose intolerant, consult your doctor before taking this medicine. Do not take medicine if you are pregnant or breastfeeding.
| Business Type | Exporter, Supplier, Trader |
| Form | Tablet |
| Packaging | Strip |
| Usage | Breast Cancer |
| Brand | Fempro |
| Packaging Size | 5 X 10 Tablets |
| Salt Composition | Letrozole Tablets |
Fempro 2.5mg is an anti-cancer drug that belongs to the class aromatase inhibitor. It is indicated as a supportive therapy after the main therapy or first-line therapy for postmenopausal women with early and advanced breast cancer whose tumors are hormone receptor-positive. Since high amounts of estrogen are found to trigger breast cancer, this medicine reduces the levels of the female reproductive hormone by blocking the enzyme (aromatase) that is involved in the production of estrogen. This medicine aims to slow or stop the growth and/or spreading to other body parts.
Inform your physician if you have not attained menopause yet, as this medicine does not work for premenopausal women. Since this medicine tends to reduce the levels of female reproductive hormones, it is not advised for menstruating women as it is related to causing fertility issues. It is advised to keep track of your cholesterol levels as this medicine tends to elevate cholesterol levels. Fempro 2.5mg could also decrease bone mineral density. Hence, discuss with your physician and consider monitoring your bone parameters regularly. It is advised to use effective birth control during the treatment and at least 3 weeks after the last dose.
| Business Type | Exporter, Supplier |
| Composition | Gefitinib |
| Dosage Form | Tablet |
| Brand Name | Geffy |
| Packaging Size | 30 Tablets |
| Dose/Strength | 250 Mg |
| Marketer | INTAS PHARMACEUTICALS LTD |
Geffy 250mg Tablet is an antineoplastic drug belonging to the tyrosine kinase inhibitors, containing the active ingredient Gefitinib. It is used to treat non-small cell lung cancer. Non-small cell lung cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner in the tissues of the lung. It is used in patients where the NSCLC cancer has spread to other parts of the body, who have certain types of abnormal epidermal growth factor (EGFR) genes, and patients who have not received any cancer treatment.
Some formulations of this drug may contain lactose as an inactive ingredient in which the body is unable to digest lactose, a sugar found in milk and dairy products. It can cause symptoms such as bloating, and abdominal pain. If you have lactose intolerance, inform your doctor before starting this therapy. Talk with your healthcare provider if you have kidney or liver disease, vision problems, lung problems, or taking any blood thinner like warfarin. Your healthcare provider will check regular blood tests to prevent complications. Avoid consuming alcohol as it may cause dizziness.
Consult your doctor before using this medication if you are pregnant or plan to have a baby. These tablets are unsafe to use during pregnancy as it causes harm to an unborn fetus. Your healthcare practitioner will conduct a pregnancy test before you start treatment with this tablet. Discuss with your doctor effective birth control methods and utilize them for at least two weeks following the last dose. Avoid breastfeeding your baby while on the treatment as it is unknown if this drug passes into the breast milk.
| Business Type | Exporter, Supplier |
| Packaging Size | 30 Tablets |
| Composition | Gefitinib |
| Packaging Type | Box |
| Manufactured By | Natco |
| Strength | 250 Mg |
| Form | Tablet |
Geftinat 250mg Tablet is an antineoplastic drug belonging to the tyrosine kinase inhibitors, containing the active ingredient Gefitinib. It is used to treat non-small cell lung cancer. Non-small cell lung cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner in the tissues of the lung. It is used in patients where the NSCLC cancer has spread to other parts of the body, who have certain types of abnormal epidermal growth factor (EGFR) genes, and patients who have not received any cancer treatment.
Some formulations of this drug may contain lactose as an inactive ingredient in which the body is unable to digest lactose, a sugar found in milk and dairy products. It can cause symptoms such as bloating, and abdominal pain. If you have lactose intolerance, inform your doctor before starting this therapy. Talk with your healthcare provider if you have kidney or liver disease, vision problems, lung problems, or taking any blood thinner like warfarin. Your healthcare provider will check regular blood tests to prevent complications. Avoid consuming alcohol as it may cause dizziness.
Consult your doctor before using this medication if you are pregnant or plan to have a baby. These tablets are unsafe to use during pregnancy as it causes harm to an unborn fetus. Your healthcare practitioner will conduct a pregnancy test before you start treatment with this tablet. Discuss with your doctor effective birth control methods and utilize them for at least two weeks following the last dose. Avoid breastfeeding your baby while on the treatment as it is unknown if this drug passes into the breast milk.
| Business Type | Exporter, Supplier |
| Brand | Gemivo |
| Packaging | Vial |
| Strength | 1 G |
| Dosage Form | Injection |
| Composition | Gemcitabine |
| Manufacturer By | Medicaman |
Gemivo 1000mg injection is a chemotherapy medication containing the active ingredient gemcitabine. It is used to treat bladder, breast, ovarian, pancreatic, and non-small cell lung cancers. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. Talk to your doctor if you have heart disease, liver disorders, kidney disorders, recently had radiotherapy, or vaccinated before taking this medicine.
Gemivo 1000mg injection is not recommended for adolescents and children under the age of 18. Your doctor will assess your blood cell counts and kidney and liver function each time you are given this medicine. Use effective birth control during the treatment and at least six months after the last dose. Gemivo 1000mg injection may impair fertility in male patients. Men taking this medicine are advised not to father a child during the treatment and for 6 months after the treatment.
Tell your physician if you are on a salt-controlled diet, as this medicine contains sodium. Report to your doctor immediately if you experience shortness of breath, wheezing, changes in color or volume of urine, bleeding, or upper abdominal pain while taking Gemivo 1000mg injection.
| Business Type | Exporter, Supplier |
| Composition | Gemcitabine |
| Packaging Size | Vial |
| Salt Composition | Gemcitabine Injection |
| Strength | 200 Mg |
| Brand | Gemivo |
| Marketer | MEDICAMEN BIOTECH LTD |
Gemivo 200mg injection is a chemotherapy medication containing the active ingredient gemcitabine. It is used to treat bladder, breast, ovarian, pancreatic, and non-small cell lung cancers. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. Talk to your doctor if you have heart disease, liver disorders, kidney disorders, recently had radiotherapy, or vaccinated before taking this medicine.
Gemivo 200mg injection is not recommended for adolescents and children under the age of 18. Your doctor will assess your blood cell counts and kidney and liver function each time you are given this medicine. Use effective birth control during the treatment and at least six months after the last dose. Gemivo 200mg injection may impair fertility in male patients. Men taking this medicine are advised not to father a child during the treatment and for 6 months after the treatment.
Tell your physician if you are on a salt-controlled diet, as this medicine contains sodium. Report to your doctor immediately if you experience shortness of breath, wheezing, changes in color or volume of urine, bleeding, or upper abdominal pain while taking Gemivo 200mg injection.
| Business Type | Exporter, Supplier |
| Brand | Glenza |
| Strength | 40 Mg |
| Usage | Advanced Prostate Cancer |
| Composition | Enzalutamide |
| Dosage Form | Capsule |
| Packaging Size | 112 Capsules |
| Manufacturer | Glenmark Pharma |
Glenza Capsule contains the active ingredient Enzalutamide. It is an antineoplastic drug that belongs to the category of medicines known as androgen receptor inhibitors. This medication is used in the treatment of advanced prostate cancer in patients who do not respond to surgical or hormonal treatments.
It is not recommended to take Glenza Capsule if you are allergic to enzalutamide or any of its ingredients. During the Glenza Capsule treatment, your doctor may periodically monitor for Prostate-specific antigen (PSA) tests. This blood test measures the level of PSA, a protein produced by the prostate gland that can be elevated in men with prostate cancer. PSA levels can help monitor the progression of the disease and the response to treatment. Other tests also include liver function tests and complete blood count(CBC) to prevent serious complications.
This medicine can cause seizures, so patients with a history of seizures should use caution when taking this medication. Avoid grapefruit and grapefruit juice while taking Glenza Capsule, as it can increase the levels of the medication in the body. This drug is not recommended during pregnancy as it causes harm to the unborn baby, and it also causes fertility issues, inform your doctor about any fertility concern you may have before starting treatment with this medicine. Before beginning this treatment, tell your healthcare provider if you are pregnant or planning to have a baby. It is advised for both men and women to follow proper contraceptive methods during and for 3 months after the last dose of Glenza Capsule.
| Business Type | Exporter, Supplier |
| Brand | Glenza |
| Strength | 80 Mg |
| Usage | Advanced Prostate Cancer |
| Dosage Form | Capsule |
| Packaging Size | 56 Capsules |
| Manufacturer By | Glenmark Pharma |
| Marketer | Glenmark |
Glenza 80mg capsule contains the active ingredient Enzalutamide. It is an antineoplastic drug that belongs to the category of medicines known as androgen receptor inhibitors. This medication is used in the treatment of advanced prostate cancer in patients who do not respond to surgical or hormonal treatments.
It is not recommended to take this capsules if you are allergic to any of its ingredients. During the treatment, your doctor may periodically monitor for Prostate-specific antigen (PSA) tests. This blood test measures the level of PSA, a protein produced by the prostate gland that can be elevated in men with prostate cancer. PSA levels can help monitor the progression of the disease and the response to treatment. Other tests also include liver function tests and complete blood count(CBC) to prevent serious complications.
This medicine can cause seizures, so patients with a history of seizures should use caution when taking this medication. Avoid grapefruit and grapefruit juice while taking this drug, as it can increase the levels of the medication in the body. This drug is not recommended during pregnancy as it causes harm to the unborn baby, and it also causes fertility issues, inform your doctor about any fertility concern you may have before starting treatment with this medicine. Before beginning this treatment, tell your healthcare provider if you are pregnant or planning to have a baby. It is advised for both men and women to follow proper contraceptive methods during and for 3 months after the last dose of Azel 40mg capsule.
| Business Type | Exporter, Supplier |
| Brand Name | Glioz |
| Packaging Type | Box |
| Form | Capsule |
| Strength | 20 Mg |
| Capsules Per Pack | 5 Capsules |
| Usage | Brain Tumor |
| Manufacturer | DR REDDY'S LABORATORIES LTD |
Glioz 20mg Capsule contains the active ingredient temozolomide. It belongs to the class of medications known as Antitumor agents. It is prescribed to treat brain cancer, such as glioblastoma multiforme in adults and malignant glioma, including glioblastoma multiforme or anaplastic astrocytoma in patients older than three years. Glioblastoma and anaplastic astrocytoma are the most common and aggressive brain cancers with low chances of survival. Anaplastic astrocytoma is treated with Glioz 20mg Capsule or radiotherapy after biopsy, whereas Glioblastoma multiforme is treated with a combination of radiotherapy and Glioz 20mg Capsule, and it is continued as maintenance therapy.
The common side effects that are likely to associate with Glioz 20mg Capsule are nausea, vomiting, dizziness, diarrhea, constipation, hair loss, rashes, tiredness, frequent urination, vision and hearing problems, high blood sugar levels, muscle damage, pain in muscles and joints, memory loss, coordination problems, infections, sleep problems and loss of weight. Inform your doctor if any of these symptoms disturb you or persist.
Inform your physician if you are allergic to Glioz 20mg Capsule and its ingredients. Before starting treatment with this medication, let your physician know if you have hepatitis B infection, anemia, low platelet count, low level of RBC and WBC, blood clotting problems, or any liver or kidney problems. Your physician will monitor your WBC and platelet counts regularly. Avoid taking this medication if you are pregnant or breastfeeding. Both women and men should use birth control to avoid pregnancy and fathering a child.
| Business Type | Exporter, Supplier |
| Brand Name | Herduo |
| Application | HER2+ Breast Ca |
| Composition | Lapatinib |
| Packaging Size | 30 Tablets |
| Strength | 250 Mg |
| Salt Composition | Lapatinib |
Herduo 250mg Tablet contains the active ingredient lapatinib. It is indicated to treat advanced breast cancer and it may be used alone or in combination with other medications. It is effective against cells sensitive to hormones and rapidly multiplying cancer cells that produce most of the protein called human epidermal growth receptor -2.
The common side effects that are likely to occur while you are on the treatment with Herduo 250mg Tablet are nausea, vomiting, tiredness, weakness, itching, dry skin, loss of appetite, indigestion, constipation, mouth ulcers, stomach pain, difficulty in sleeping, joint or back pain, cough, breathing problems, headache, etc. If you experience severe allergic reactions, skin rashes, heart, liver, and lung problems, report your physician immediately.
Inform your healthcare provider at the first sign of diarrhea or dehydration. Monitor your blood pressure regularly while taking Herduo 250mg Tablet. If you have diarrhea while taking this medication, drink plenty of fluids, eat low-fat, high-protein foods, and avoid milk and its products and herbal supplements.
| Business Type | Exporter, Supplier |
| Application | HER2+ Breast Ca |
| Brand Name | Hertab 250mg Lapatinib Tablet,Hertab |
| Composition | Lapatinib |
| Packaging Size | 30 Tablets |
| Form | Tablet |
| Strength | 250 Mg |
Hertab 250mg Tablet contains the active ingredient lapatinib. It is indicated to treat advanced breast cancer and it may be used alone or in combination with other medications. It is effective against cells sensitive to hormones and rapidly multiplying cancer cells that produce most of the protein called human epidermal growth receptor -2.
The common side effects that are likely to occur while you are on the treatment with Hertab 250mg Tablet are nausea, vomiting, tiredness, weakness, itching, dry skin, loss of appetite, indigestion, constipation, mouth ulcers, stomach pain, difficulty in sleeping, joint or back pain, cough, breathing problems, headache, etc. If you experience severe allergic reactions, skin rashes, heart, liver, and lung problems, report your physician immediately.
Inform your healthcare provider at the first sign of diarrhea or dehydration. Monitor your blood pressure regularly while taking Hertab 250mg Tablet. If you have diarrhea while taking this medication, drink plenty of fluids, eat low-fat, high-protein foods, and avoid milk and its products and herbal supplements. Hertab tablet price India varies by retailer and location.